drugset / Trial / NCT01442337
A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to evaluate the efficacy, safety and tolerability of a single intravenous dose of ASP8597 in kidney transplant recipients.
Timeline
- Start
- 2011-12
- Primary completion
- 2013-07
- Completion
- 2013-07
Outcome
Outcome not reported
Stopped (Business): “Study was terminated by sponsor decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DIANEXIN | Unknown | — | Intravenous |
Indications
No indication recorded.